Hill-Rom Holdings Inc (NYSE:HRC) – Northcoast Research lifted their Q1 2018 EPS estimates for Hill-Rom Holdings in a research report issued on Monday. Northcoast Research analyst D. Keiser now anticipates that the medical technology company will earn $0.90 per share for the quarter, up from their previous forecast of $0.87. Northcoast Research also issued estimates for Hill-Rom Holdings’ Q2 2018 earnings at $0.95 EPS, Q3 2018 earnings at $1.05 EPS, Q4 2018 earnings at $1.48 EPS and FY2018 earnings at $4.38 EPS.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $689.10 million for the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.81 EPS.

TRADEMARK VIOLATION WARNING: “Equities Analysts Set Expectations for Hill-Rom Holdings Inc’s Q1 2018 Earnings (HRC)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/08/04/equities-analysts-set-expectations-for-hill-rom-holdings-incs-q1-2018-earnings-hrc.html.

Several other research firms also recently issued reports on HRC. BidaskClub downgraded Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Zacks Investment Research downgraded Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Needham & Company LLC reduced their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a report on Friday, July 28th. Barclays PLC upped their price objective on Hill-Rom Holdings from $80.00 to $86.00 and gave the stock an “overweight” rating in a report on Friday, June 9th. Finally, Cantor Fitzgerald assumed coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price objective on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $88.17.

Shares of Hill-Rom Holdings (NYSE HRC) traded up 0.07% during mid-day trading on Wednesday, reaching $75.32. The company’s stock had a trading volume of 505,649 shares. The firm has a market capitalization of $4.96 billion, a P/E ratio of 43.89 and a beta of 1.22. The company has a 50 day moving average of $80.60 and a 200-day moving average of $72.15. Hill-Rom Holdings has a 12 month low of $50.50 and a 12 month high of $84.65.

Several hedge funds and other institutional investors have recently bought and sold shares of HRC. BNP Paribas Arbitrage SA increased its position in Hill-Rom Holdings by 101.1% in the second quarter. BNP Paribas Arbitrage SA now owns 30,431 shares of the medical technology company’s stock worth $2,423,000 after buying an additional 15,296 shares during the period. Bernzott Capital Advisors increased its position in Hill-Rom Holdings by 4.0% in the second quarter. Bernzott Capital Advisors now owns 274,312 shares of the medical technology company’s stock worth $21,838,000 after buying an additional 10,575 shares during the period. Comerica Bank increased its position in Hill-Rom Holdings by 0.9% in the second quarter. Comerica Bank now owns 69,319 shares of the medical technology company’s stock worth $5,830,000 after buying an additional 620 shares during the period. Legal & General Group Plc increased its position in Hill-Rom Holdings by 24.8% in the second quarter. Legal & General Group Plc now owns 53,284 shares of the medical technology company’s stock worth $4,242,000 after buying an additional 10,596 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Hill-Rom Holdings by 53.0% in the second quarter. Bank of New York Mellon Corp now owns 1,235,608 shares of the medical technology company’s stock worth $98,367,000 after buying an additional 427,888 shares during the period. 83.94% of the stock is currently owned by institutional investors.

In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of the company’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total transaction of $150,239.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares in the company, valued at approximately $2,279,036.56. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is 41.62%.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History and Estimates for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.